ETR:LXS - Lanxess Stock Price, Forecast & News

€61.02

+0.02 (+0.03 %)

(As of 12/13/2019 03:53 PM ET)

Add

Compare

Today's Range

€60.96

Now: €61.02▼

€62.72

50-Day Range

€58.30

MA: €61.00▼

€63.88

52-Week Range

€39.47

Now: €61.02▼

€64.58

Volume274,007 shs

Average Volume312,027 shs

Market Capitalization$5.34 billion

P/E Ratio15.49

Dividend Yield1.52%

BetaN/A

LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals. Read More…

Industry, Sector and Symbol

Stock Exchange ETR

Industry Specialty Chemicals

Sub-IndustryN/A

SectorBasic Materials

Current SymbolETR:LXS

Previous Symbol

CUSIPN/A

CIKN/A

Webhttp://lanxess.de/

Phone+49-221-88850

Debt

Debt-to-Equity Ratio102.70

Current Ratio2.70

Quick Ratio1.54

Price-To-Earnings

Trailing P/E Ratio15.49

Forward P/E Ratio13.84

P/E GrowthN/A

Sales & Book Value

Annual Sales$7.18 billion

Price / Sales0.74

Cash Flow€12.90 per share

Price / Cash Flow4.73

Book Value€31.93 per share

Price / Book1.91

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees14,649

Outstanding Shares87,447,904

Market Cap$5.34 billion

Next Earnings DateN/A

OptionableNot Optionable

Receive LXS News and Ratings via Email

Sign-up to receive the latest news and ratings for LXS and its competitors with MarketBeat's FREE daily newsletter.

Lanxess (ETR:LXS) Frequently Asked Questions

What is Lanxess' stock symbol?

Lanxess trades on the ETR under the ticker symbol "LXS."

What price target have analysts set for LXS?

18 Wall Street analysts have issued 12 month price targets for Lanxess' shares. Their forecasts range from €50.00 to €88.00. On average, they anticipate Lanxess' share price to reach €64.00 in the next twelve months. This suggests a possible upside of 4.9% from the stock's current price. View Analyst Price Targets for Lanxess.

What is the consensus analysts' recommendation for Lanxess?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Lanxess in the last year. There are currently 1 sell rating, 12 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Lanxess.

Has Lanxess been receiving favorable news coverage?

News coverage about LXS stock has been trending positive this week, InfoTrie reports. The research firm ranks the sentiment of news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Lanxess earned a media sentiment score of 2.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near future. View News Stories for Lanxess.

Who are some of Lanxess' key competitors?

Some companies that are related to Lanxess include Symrise (SY1), Orica (ORI), Covestro (1COV), Brenntag (BNR), Croda International (CRDA), Johnson Matthey (JMAT), Victrex (VCT), Synthomer (SYNT), Elementis (ELM), Chemtrade Logistics Income Fund (CHE.UN), Scapa Group (SCPA), Zotefoams (ZTF), Ecosynthetix (ECO), Calix (CXL) and Nano One Materials (NNO).

What other stocks do shareholders of Lanxess own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lanxess investors own include CVS Health (CVS), Covestro (1COV), Affimed (AFMD), Universal Display (OLED), General Electric (GE), Commerzbank (CBK), Henkel AG & Co KGaA (HEN3), Admiral Group (ADM), Rio Tinto (RIO) and Celgene (CELG).

Who are Lanxess' key executives?

Lanxess' management team includes the folowing people:

Mr. Matthias Zachert, Chairman of Management & CEO (Age 52)
Mr. Michael Pontzen, CFO & Member of the Board of Management (Age 50)
Dr. Rainier van Roessel, Labor Relations Director & Member of the Board of Management (Age 62)
Dr. Hubert Fink, Member of the Board of Management (Age 57)
André Simon, Head of Investor Relations

What is Lanxess' stock price today?

One share of LXS stock can currently be purchased for approximately €61.02.

How big of a company is Lanxess?

Lanxess has a market capitalization of $5.34 billion and generates $7.18 billion in revenue each year. Lanxess employs 14,649 workers across the globe.View Additional Information About Lanxess.

What is Lanxess' official website?

The official website for Lanxess is http://lanxess.de/.

How can I contact Lanxess?

Lanxess' mailing address is Konzernzentrale, Kennedyplatz 1, KOELN, 50569, Germany. The company can be reached via phone at +49-221-88850.

MarketBeat Community Rating for Lanxess (ETR LXS)

Community Ranking:		2.4 out of 5 ( )
Outperform Votes:		330 (Vote Outperform)
Underperform Votes:		351 (Vote Underperform)
Total Votes:		681

MarketBeat's community ratings are surveys of what our community members think about Lanxess and other stocks. Vote "Outperform" if you believe LXS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LXS will underperform the S&P 500 over the long term. You may vote once every thirty days.

This page was last updated on 12/13/2019 by MarketBeat.com Staff